Antibody Titers After a Third and Fourth SARS-CoV-2 Vaccine Dose in Bizen City, Japan

• Tomoka Kadowaki,
• Ayako Sasaki,
• Naomi Matsumoto,
• Toshiharu Mitsuhashi,
• Soshi Takao,
• Takashi Yorifuji

Affiliations

Tomoka Kadowaki

Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Ayako Sasaki

Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Naomi Matsumoto

Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Toshiharu Mitsuhashi

Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan

Soshi Takao

Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Takashi Yorifuji

Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan